Uglyanica K N, Fomin K A, Nefyodov L I, Nowicky J W, Brzosko W J, Jankowski A
Medical Institute, Grodno, Belarus.
Drugs Exp Clin Res. 1996;22(3-5):123-5.
Studies were undertaken to evaluate the influence of Ukrain on the postoperative period in patients with breast cancer. The group under Ukrain medication was comprised of 10 patients in stage T1-3NO-1MO. The control group was comprised of 22 patients in the same clinical and laboratory staging as those treated with Ukrain in the first year of postoperative follow-up metastatic lymph nodes were observed in one patient from the control group. It is planned to enlarge the groups and to continue the observation up to the third year to obtain reliable and more statistically significant data.
开展了多项研究以评估 Ukrain 对乳腺癌患者术后阶段的影响。接受 Ukrain 药物治疗的组由 10 例 T1 - 3NO - 1MO 期患者组成。对照组由 22 例处于与接受 Ukrain 治疗的患者相同临床和实验室分期的患者组成。在术后随访的第一年，对照组有 1 例患者出现转移性淋巴结。计划扩大样本量并将观察持续到第三年，以获得可靠且更具统计学意义的数据。
